Researchers from IRSJD and IRB Barcelona unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues

A team from Institut de Recerca Sant Joan de Déu and IRB Barcelona has studied the cases of four children who have experienced two cancers during childhood and has addressed the origin of the second tumour. The work has been published in the journal Cancer Discovery.

  1. IRSJD and IRB Barcelona strengthen their research collaboration in pediatric cancer

    The agreement includes the opening of a laboratory, led by Dr. Alexandra Avgustinova, which will address the specific vulnerabilities of developmental tumours to discover new therapeutic approaches. The shared Pediatric Cancer Epigenetics laboratory will be located on IRB Barcelona premises.

  2. The first clinical trial of a gene therapy for Duchenne in children under 4 years old is initiated.

    A research team from the Institut de Recerca Sant Joan de Déu · SJD Barcelona Children's Hospital is participating in an international clinical trial of a gene therapy for Duchenne muscular dystrophy in children under 4 years old.

  1. Nanomedicine to tackle rare diseases

    Experts in nanomedicine from various fields have gathered today for the fifth consecutive year at Nano Rare Diseases Day. This event is co-organized by IRSJD and the NANOMED Spain platform, coordinated by IBEC.

  2. SJD Barcelona Children’s Hospital and IRSJD coordinate a European project to improve pediatric palliative care

    SJD Barcelona Children's Hospital will lead a consortium consisting of 17 partners from 10 European countries, named Palliakid. The inaugural consortium meeting is scheduled to take place today in Barcelona.

  3. An ultrasound test at the end of pregnancy detects at-risk babies and prevents severe complications

    A multicenter study, published in The Lancet and involving the Institut de Recerca Sant Joan de Déu, has shown that adding a Doppler study of fetal circulation in the last ultrasound can reduce by half the complications requiring admission to the neonatal intensive care unit (ICU) for full-term babies.

  4. Carmen Muñoz-Almagro has been honored by the Barcelona Medical Association for her career in biomedical research

    Dr. Carmen Muñoz-Almagro, a researcher from the Institut de Recerca Sant Joan de Déu, has been honored with one of the Professional Excellence Awards, which are annually bestowed by the Barcelona Medical Association.

  5. Advances in Research on Rett Syndrome

    A study conducted by the Paediatric Neurometabolic Disorders: Neural Communication Mechanisms and Personalised Therapies Group at IRSJD · SJD Barcelona Children's Hospital confirms mitochondrial dysfunction in two distinct models of Rett syndrome, highlighting the significance of distinguishing between brain regions and stages of the disease. The findings of this study open up new avenues for treatment development.

  6. Gate2Brain recognized by the Wild Card program at Pediatric Innovation Day

    The Wild Card program in the field of pediatrics, powered by EIT Health and the pediatric innovation hub i4KIDS, has selected the start-up Gate2Brain to participate in its acceleration program.